≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Other erythematous conditions

DOID EFO MESH SNOMED Endpoint Browser PheWeb

L12_ERYTHEMATOUSOTH

erythematosquamous dermatosis: Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector

Check pre-conditions, main-only, mode, registry filters None

0 out of 7 registries used, show all original rules.

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

1006

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

965

diagram downward connector
L12_ERYTHEMATOUSOTH

Control definitions

Control exclude L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

No data for upset plot.

No data for upset table.

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 965 612 353
Unadjusted prevalence (%) 0.23 0.27 0.19
Mean age at first event (years) 50.79 50.04 52.09

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.08 3.83 [2.71, 5.40] 2.0e-14 107
15 years 0.01 1.69 [1.11, 2.58] 1.4e-2 41
5 years 0.00 3.14 [1.82, 5.41] 3.9e-5 32
1 year 0.00 5.68 [2.63, 12.24] 9.5e-6 12

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_ERYTHEMATOUSOTH – Other erythematous conditions
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Other erythematous conditions
after Other erythematous conditions

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other erythematous conditions

↥

Endpoint not on priority list, no data to show.